These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4679249)

  • 1. [Metabolism of glibornuride in the human].
    Bigler F; Quitt P; Vecchi M; Vetter W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2191. PubMed ID: 4679249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of glibornuride].
    Rentsch G; Schmidt HA; Rieder J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotransformation of a new hypoglycemic agent, N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) in humans and rats.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(1):37-46. PubMed ID: 7454610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.
    Fuccella LM; Tamassia V; Valzelli G
    J Clin Pharmacol New Drugs; 1973; 13(2):68-75. PubMed ID: 4631138
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
    Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of glibornuride (a tolylsulfonyl urea hypoglycemic agent) in blood by differential pulse polarography.
    De Silva JA; Hackman MR
    Anal Chem; 1972 Jun; 44(7):1145-51. PubMed ID: 4658149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 10. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 12. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 13. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 14. [Potentiation of the hypoglycemic effect of sulfonylurea derivatives by drugs. II. Pharmacokinetics and metabolism of glibenclamide (HB 419) in presence of phenylbutazone].
    Schulz E; Koch K; Schmidt FH
    Eur J Clin Pharmacol; 1971 Dec; 4(1):32-7. PubMed ID: 5004903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolism of thiazanol in rats and dogs].
    Queisnerová M; Zikmund E; Svátek E
    Cesk Farm; 1971 Jan; 20(1):15-7. PubMed ID: 5546594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glibornuride (Glutril). A new peroral antidiabetic agent].
    Jervell J
    Tidsskr Nor Laegeforen; 1974 Mar; 94(9):589. PubMed ID: 4828084
    [No Abstract]   [Full Text] [Related]  

  • 18. [New compounds and reactions of sulfonamides with amines. XVI. Preparation and study of hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-N'[(1-pyrazolyl) -alkyl] urea].
    Brzozowski Z; Pac-Pomarnacka E; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(4):461-7. PubMed ID: 970168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
    Speck U; Mützel W; Kolb KH; Acksteiner B; Schulze PE
    Arzneimittelforschung; 1974 Mar; 24(0):404-9. PubMed ID: 4408089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacobiochemistry and pharmacokinetics of the spasmolytic -diethyl-aminoethyl-( -methyl-2,5-endomethylene- 3 -tetrahydrobenzhydryl)-ether bromomethylate].
    Rauen HM; Schriewer H; Eimermacher H
    Arzneimittelforschung; 1972 Apr; 22(4):675-81. PubMed ID: 5068246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.